期刊文献+

维生素D类似物对心肌肥厚的抑制作用 被引量:5

Inhibited Effects of Vitamin D Analogs on Cardiac Hypertrophy
下载PDF
导出
摘要 目的探讨维生素D类似物对自发性高血压大鼠(SHRs)心肌肥厚的治疗作用。方法选取20只1个月大雄性SHR,随机分成高血压对照组(C组,n=5)、洛沙坦组(L组,n=5)、帕立骨化醇组(P组,n=5)、洛沙坦与帕立骨化醇联合用药组(LP组,n=5),进行2个月不同干预。HE染色观察SHR左心室横断面变化,异硫氰酸荧光素标记的麦胚凝集素对左心室细胞膜染色观察心肌细胞变化,Image J软件测量心肌细胞直径大小。Northern blot法观察心肌细胞中心钠素(ANP)和脑钠素(BNP)mRNA的表达。Western blot法观察肾脏中肾素蛋白水平表达,实时定量PCR观察肾脏中mRNA水平表达,RT-PCR法观察心脏中肾素mRNA水平改变。结果与C组相比,P组出现左心室壁变薄,但LP组左心室壁变薄更明显,C组心肌细胞大且间质增生而LP组的细胞最小(P<0.01)、间质最少。心肌细胞中ANP和BNP的mRNA表达量在LP组最低(P均<0.05)。肾脏中肾素蛋白在L组表达水平最高、在LP组表达明显降低,肾脏中肾素mRNA在L组表达最高、在P组表达最低(P均<0.05),心脏中的肾素mRNA在L组表达水平最强、在LP组表达水平明显降低。结论维生素D类似物与洛沙坦在抑制左心室心肌肥厚中起协同作用。 Objective To study the contribution of vitamin D analogs on cardiac hypertrophy in spontaneously Hypertensive Rats. Methods Twenty male SHR rats were randomly divided into hypertension control group ( C group, n = 5) , losartan group ( L group, n = 5) , paricalcitol group (P group, n = 5) , losartan + paricalcitol group ( LP group, n = 5 ) , and there rats were intervene them for 2 months. Staining cross - sections of left ventricles with HE was performeol to observe its change. Cardiomyocytes were stained with FITC labeled wheat germ agglutinin and viewed by a fluorescence microscope. Diameter of cardiomyocytes was measured by computer software Image J. The expression of ANP and BNP mRNA in cardiomyocytes were detected by Northern blot. Renin in kidney protein expression was detected by Western blot. the expression of renin mRNA in kidney was observed by real time PCR. observes the expression of renin mRNA in heart was obserred by RT - PCR. Results Compared with C group, P group's left ventrieular become thin and LP group's left ventricular become thinner, C group's cardiomyocytes was big and stroma hyperplasia but LP group's eardiomyoeytes was the smallest ( P 〈 0.01 ) and stroma was few. LP group's mRNA expresstion of ANP and BNP in cardiomyocytes was the lowest( P 〈 0.05 ). L group' s Renin protein in kidney expression was highest, and the expression in LP group become absolutely low. The expression of renin mRNA in kidney in L group was highest and in P group was lowest (P 〈 0.05). The expression of renin mRNA in heart in L group is highest in LP group was lowest (P 〈 0.05). Conclusion The combination of vitamin D analogs with losartan generates a degree of therapeutic syn- ergism in the attenuation of left ventricular hypertrophy.
出处 《医学研究杂志》 2015年第6期31-35,共5页 Journal of Medical Research
基金 国家自然科学基金资助项目(30971401 81170065) 辽宁省攀登学者计划项目 辽宁省十百千计划项目
关键词 自发性高血压大鼠 维生素D类似物 心肌肥厚 Spontaneously hypertensive rats Vitamin analogs Cardiac hypertrophy
  • 相关文献

参考文献8

  • 1李敏,于慧会,时景璞.25羟维生素D水平与心血管疾病关系的Meta分析[J].中华疾病控制杂志,2011,15(11):939-942. 被引量:20
  • 2Wang TJ, Pencina M J, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease [ J ]. Circulation, 2008,117:503 - 511.
  • 3Giovannucci E, Liu Y, Hollis BW, et al. : 25 - hydroxyvitamin D and risk of myocardial infarction in men: a prospective study [ J ]. Arch Intern Med, 2008,168(12) :1174 - 1180.
  • 4Yuan W, Pan W, Kong J, et al. 1,25 - Dihydroxyvitamin D3 sup- presses renningene transcription by blocking the activity of the cyclic AMP response elementin the renin gene promoter. [ J] J Biol Chem 2007,282(9):29821-29830.
  • 5陈玲,邹栩.全球心血管药物研发动态[J].中国新药杂志,2010,19(1):8-16. 被引量:12
  • 6Ebert R, Schutze N, Adamski J, et al. Vitamin D signaling is modu- lated on multiple levels in health and disease [ J ]. Mol Cell Endocri- nol,2006,248(1-2) :149-159.
  • 7吴淑燕,顾洒洒,李晓莉,张岩.维生素D类似物帕立骨化醇的药理作用研究进展[J].中国药学杂志,2011,46(22):1700-1703. 被引量:6
  • 8Lakshmikanthan S, Zieba B J, Ge ZD, et al. Ras - related protein 1 in smooth muscle and endothelium is required for maintenance of vas- cular tone and normal blood pressure[ J]. Arteriosclerosis Thrombosis and Vascular Biology, 2014, 34 (7) : 1486 - 1494.

二级参考文献72

  • 1调脂药Vytorin和Zocor之战FDA最终支持Vytorin[EB/OL].(2009 - 02 - 17 ). [ 2009 - 09 - 15 ]. http ://www. 39kf. corn/ medicine/news/xy/2009 - 02 - 17 - 565864. shtml.
  • 2GREENER M. Cardiovascular medicines: flogging pharma's dead horse? [ J/OL]. [ 2009 -03 - 23 ]. http://www, scripnews. com/home/analysis/Exec ative-B riefing-Cardiovascular-medicines - flogging-pharmas-dead-horse-132532 ? autnID =/contentstore/ scripnews/codex/2816e6dO-1550-11 de-9 c89-7 f3 fOdef3 edc. xml.
  • 3新一代抗血栓药物--戊聚糖钠(Arixtra)[EB/OL].(2009-09 - 14). [ 2009 - 09 - 15 ]. http ://heart. gzbaozhilin, corn/New Drugs/other/200903/2807. html.
  • 4WIVIOTT SD, BRAUNWALD E, MCCABE CH,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes[J].N Engl J Med,2007,357 ( 20 ) :2001 - 2015.
  • 5新的抗血小板药物替卡格雷可能挑战氯吡格雷、普拉格雷[ EB/OL]. (2009 - 07 - 13 ). [ 2009 -09 - 16 ]. http ://www. bhli. org. en/show, aspx? id = 2675&eid = 5.
  • 6ROSENSON RS,HISLOP C ,MCCONNELL D,et al. Effects of 1- H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 ( PLASMA study) : a phase I1 double-blind, randomized, placebo-controlled trial [ j ]. Lancet, 2009, 373 (9664) :649 - 658.
  • 7Lp-PLA2抑制剂darapladib:拨开云雾见青天?[N].医药经济报,2009-01-08(8).
  • 8Novaris.与利尿剂相比,首个直接肾素抑制剂Rasilez能更有效地降低肥胖人群的血压[EB/OL].(2008-09-09).[2009 -09 - 16 ]. http ://www. novartis, com. cn/nov/article. shtml? article_id = 367.
  • 9LAURIE B. Higher-dose candesartan may help reduce persistent proteinuria [ J/OL ]. MedscapeMedicaiNews, 2009 - 02 - 13 [2009 -09 - 16 ]. http://cme, medscape, com/viewarticle/ 588237; meddomainjsession = hYldKclM5pLPbXJTY8sHv679 FfMPdH2w7fcpzbGFJPSwNDzTjJvk ! -874340708.
  • 10Merck discontinues rolofylline following Phase III trial results [ EB/OL]. (2009 - 06 - 10). [2009 - 09 - 16 ]. http://www. pharmaprojects, com/news/1006_1438, htm.

共引文献35

同被引文献42

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部